Medications for weight loss in patients with Type 2 diabetes mellitus

MOspace/Manakin Repository

Breadcrumbs Navigation

Medications for weight loss in patients with Type 2 diabetes mellitus

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/13372

[+] show full item record


Title: Medications for weight loss in patients with Type 2 diabetes mellitus
Author: Kachowski, Larisa; Over, Darrell R.; Qiu, Kefeng
Date: 2012-03-15
Publisher: Family Physicians Inquiries Network
Citation: American Family Physician, 85(6) 2012: 633-635.
Abstract: Fluoxetine (Prozac) and orlistat (Xenical) produce modest short-term weight loss, but their long-term benefits are unclear and their safety is uncertain. (Strength of Recommendation [SOR]: B, based on a meta-analysis of randomized controlled trials.) Topiramate (Topamax; immediate- and controlled-release formulations) can produce weight loss, but potential psychiatric and neurologic adverse effects limit its usefulness (SOR: B, based on randomized controlled trials.) Sibutramine (Meridia) produces weight loss but has been withdrawn from the U.S. market because of potential cardiovascular adverse effects.
URI: http://hdl.handle.net/10355/13372

This item appears in the following Collection(s)

[+] show full item record